Document Detail

Treatment challenges in axial spondylarthritis and future directions.
MedLine Citation:
PMID:  23888365     Owner:  NLM     Status:  In-Data-Review    
Major progress has been made in recent years in the management of axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA). Most predictors of response have been defined for TNF-blocker therapy, and new treatment strategies are being discussed about how to best reach remission and how to maintain remission. Other biologics besides TNF-blockers have been tested in AS but have so far failed. The IL-17/IL-23 cytokines currently seem to be the most interesting targets. Short-term TNF-blocker therapy does not inhibit radiographic progression but long-term might do so. NSAIDs have been proven to inhibit such progression, even after 2 years of treatment. The effect of a combined therapy of NSAIDs with TNF-blockers on the inhibition of new bone formation in AS patients is currently unknown.
Joachim Sieper
Related Documents :
7263785 - Pollen tube development in petunia hybrida following compatible and incompatible intras...
18034065 - Growth of femoral bone proximal end in normal conditions.
23503445 - A pilot study investigating tumor necrosis factor-α as a potential intervening variabl...
883485 - Quantitative changes in the cellular population of the growth plate of triamcinolone-tr...
38205 - Differential depletion of t lymphocytes in the spleen of dengue virus-infected mice.
19418485 - A2e, a component of lipofuscin, is pro-angiogenic in vivo.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current rheumatology reports     Volume:  15     ISSN:  1534-6307     ISO Abbreviation:  Curr Rheumatol Rep     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-07-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888970     Medline TA:  Curr Rheumatol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  356     Citation Subset:  IM    
Medical Department I, Rheumatology, Charitè, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ocular vasculitis.
Next Document:  Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.